Table 4 Changes in median expression and corresponding null probability values () for pair-wise comparison of disease classes and the non-fatigued control group for each individual gene in the CD19+ B cell Up-regulated gene set
| Â | 3-Class (NF Controls) | 7-Class (Controls = LCA-0 U LCA-2) | |||||
|---|---|---|---|---|---|---|---|
Gene | ISF | CFS | LCA-1 | LCA-3 | LCA-4 | LCA-5 | LCA-6 |
SP140 | -0.03 (0.60) | 0.02 (0.49) | -0.07 (0.43) | 0.10 (0.60) | 0.01 (0.72) | -0.08 (0.29) | 0.07 (0.92) |
CD22 | -0.16 (0.10) | -0.09 (0.31) | -0.14 (0.17) | -0.58 (0.02) | -0.30 (0.04) | 0.02 (0.35) | 0.05 (0.70) |
QRSL1 | -0.03 (0.95) | -0.21 (0.91) | 0.29 (0.28) | -0.10 (0.70) | 0.23 (0.50) | -0.16 (0.89) | -0.49 (0.42) |
PTPRK | -0.12 (0.55) | -0.21 (0.18) | -0.12 (0.76) | -0.07 (0.82) | -0.22 (0.68) | -0.20 (0.17) | -0.07 (0.64) |
P2RY10 | 0.01 (0.21) | -0.02 (0.51) | 0.08 (0.99) | -0.08 (0.06) | 0.28 (0.82) | 0.11 (0.94) | 0.20 (0.33) |
TSPAN3 | -0.10 (0.54) | -0.20 (0.19) | -0.24 (0.39) | -0.17 (0.83) | 0.13 (0.38) | -0.08 (0.83) | -0.02 (0.82) |